(Q46693835)

24 December 2017

title

High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation (English)

1 reference

24 December 2017

0 references

Asano-Mori Y

1

1 reference

24 December 2017

Oshima K

2

1 reference

24 December 2017

Sakata-Yanagimoto M

3

1 reference

24 December 2017

Nakagawa M

4

1 reference

24 December 2017

Kandabashi K

5

1 reference

24 December 2017

Izutsu K

6

1 reference

24 December 2017

Hangaishi A

7

1 reference

24 December 2017

Motokura T

8

1 reference

24 December 2017

Chiba S

9

1 reference

24 December 2017

Kurokawa M

10

1 reference

24 December 2017

Hirai H

11

1 reference

24 December 2017

Kanda Y

12

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

24 December 2017

Bone Marrow Transplantation

published in

1 reference

24 December 2017

volume

36

1 reference

24 December 2017

issue

9

1 reference

24 December 2017

page(s)

813-819

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705134

exact match

0 references

cites work

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705134

Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705134

Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705134

Graft-versus-tumor effect against advanced pancreatic cancer after allogeneic reduced-intensity stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705134

Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705134

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705134

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705134

Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705134

Endothelial damage caused by cytomegalovirus and human herpesvirus-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705134

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705134

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705134

7 January 2021

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705134

7 January 2021

Quantitation of cytomegalovirus: methodologic aspects and clinical applications.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705134

7 January 2021

Frequent detection of rising cytomegalovirus antigenemia after allogeneic stem cell transplantation following a regimen containing antithymocyte globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705134

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705134

1 reference

24 December 2017

release_jctnsshuongqhfkh3auz2e5v7i

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jctnsshuongqhfkh3auz2e5v7i

24 November 2022

mapped directly with Wikidata item

1 reference

24 December 2017